NeuroRPM obtains FDA 510(k) for Parkinson's monitoring on Apple Watch
The AI-powered app allows for remote monitoring of common Parkinson ' s disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch. (Source: mobihealthnews)
Source: mobihealthnews - March 24, 2023 Category: Information Technology Source Type: news
Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson's Focused Ultrasound Ablation Reduces Dyskinesia in Parkinson's
Focused ultrasound ablation significantly reduced tremors and improved mobility for patients with PD; the benefits persisted up to a year after treatment.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 3, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Unilateral Pallidal Ultrasound Ablation Beneficial in Parkinson Disease
THURSDAY, March 2, 2023 -- For patients with Parkinson disease, unilateral pallidal ultrasound ablation yields greater improved motor function or reduced dyskinesia, according to a study published in the Feb. 23 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2023 Category: Pharmaceuticals Source Type: news
Austedo XR OK'd; USPSTF's Perinatal Depression Plan; Cannabis Use Disorder Rising
(MedPage Today) -- The FDA approved a once-daily, extended-release version of deutetrabenazine (Austedo XR) in 6, 12, and 24 mg tablet strengths for adults with tardive dyskinesia and chorea associated with Huntington's disease, Teva Pharmaceuticals... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 1, 2023 Category: Psychiatry Source Type: news
Advanced Parkinson's Symptoms Improved With Focused Ultrasound
(MedPage Today) -- Unilateral focused ultrasound ablation targeted to the globus pallidus internus led to a higher percentage of Parkinson's disease patients with improved motor function or reduced dyskinesia compared with sham over 3 months but... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 23, 2023 Category: Neurology Source Type: news
FDA Okays Once-Daily Tardive Dyskinesia, Huntington Chorea Drug FDA Okays Once-Daily Tardive Dyskinesia, Huntington Chorea Drug
The US Food and Drug Administration has approved deutetrabenazine extended-release tablets (Austedo XR) for tardive dyskinesia or chorea related to Huntington disease.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - February 21, 2023 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news
Teva Announces FDA Approval of Austedo XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of Austedo
New once-daily Austedo XR regimen now approved in 6, 12, and 24 mg tablet strengths
Austedo is the only vesicular monoamine transporter 2 (VMAT2) inhibitor approved for both tardive dyskinesia (TD) and chorea associated with Huntington’s... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 17, 2023 Category: Drugs & Pharmacology Source Type: news
How Good is Cholecystectomy For Biliary Dyskinesia in Pediatric Patients?
Discussion
Biliary disease includes gallstones, cholecystitis (inflammation of the gallbladder), cholangiopathy and cholangitis (pathology of the bile ducts), biliary dyskinesia, gangrene, and cancer. Some are often overlapping as gallstones often contributing to cholecystitis and cholangitis.
Biliary dyskinesia (BD) is well-recognized in adults. Adult criteria include: “abdominal pain located in the epigastrium and/or right upper quadrant along with; buildup of pain to a steady level and lasting 30 minutes or longer, pain occurring at different intervals and not daily, severe enough to interrupt activities or lead t...
Source: PediatricEducation.org - January 30, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Which Side Are the Organs On?
Discussion
Although externally vertebrates present with bilateral symmetry, this is not necessarily true internally for humans. Humans have a normal left-right asymmetry of their internal organs. For example, the right lung has 3 lobes and is slightly larger than the left lung with 2 lobes. The normal asymmetry is called situs solitus (SS). Complete reversal of the normal abdominal and thoracic organ positions is called situs inversus totalis (SIT). Variations on the laterality between situs solitus and SIT has been referred to by different names including situs ambiguous or heterotaxy. For this case, the term situs ambigu...
Source: PediatricEducation.org - October 17, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Results from a Phase III Clinical Trial for Subcutaneous Infusion of...
Continuous subcutaneous infusion (CSCI) of levodopa/carbidopa prodrugs, foslevodopa/foscarbidopa, improved time without dyskinesia in patients with advanced Parkinson’s disease (PD) according to a...(PRWeb September 15, 2022)Read the full story at https://www.prweb.com/releases/results_from_a_phase_iii_clinical_trial_for_subcutaneous_infusion_of_foslevodopa_foscarbidopa/prweb18891204.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 15, 2022 Category: Pharmaceuticals Source Type: news
Baseline Neuromotor Abnormalities Persist in Schizophrenia Baseline Neuromotor Abnormalities Persist in Schizophrenia
Baseline dyskinesia and neurological soft signs can predict the long-term disease process of schizophrenia, new research suggests.MDedge News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 13, 2022 Category: Neurology Tags: Psychiatry News Source Type: news
Mayo Clinic receives first-of-its-kind accreditation for diagnosis of primary ciliary dyskinesia
ROCHESTER, Minn. — Mayo Clinic's Department of Laboratory Medicine and Pathology, the academic testing arm for Mayo Clinic Laboratories, has been accredited as a diagnostic site by the PCD Foundation. Mayo Clinic is the first and only center of excellence to receive PCD Foundation accreditation for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease. "This recognition of our laboratory services by the PCD Foundation is a clear reflection of our shared commitment to… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - July 7, 2022 Category: Hospital Management Source Type: news
Tardive Dyskinesia Drug Safe, Effective for Huntington's Chorea Tardive Dyskinesia Drug Safe, Effective for Huntington's Chorea
Valbenazine is effective in improving symptoms of chorea for patients with Huntington ' s disease, without any increase in suicidal ideation or suicidal behavior, phase 3 trial results show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 19, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Novel Drug Significantly Reduces Tics ― Without Side Effects Novel Drug Significantly Reduces Tics ― Without Side Effects
A drug with a novel mechanism of action reduces tics and does not cause weight gain or tardive dyskinesia ― side effects that are associated with current medications for the disorder.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 31, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
PolyCore Therapeutics raises $4.7M from investors
A Philadelphia biopharmaceutical company working on developing treatments for neurodegenerative disorders has raised $4.7 million in an equity financing deal.
PolyCore Therapeutics is developing therapies for patients suffering from dyskinesia, a condition characterized by involuntary and erratic movements of the face, arms, legs or trunk, and from cognitive impairment.
The company's lead new drug candidate, PCT-3012, is a small molecule drug being dev eloped to treat motor impairment in patients… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 22, 2022 Category: American Health Authors: John George Source Type: news
